Society
The biosimilar drugs file in Lebanon expands judicially, through oversight and government action
/file/attachments/2411/adwia_728238_555434.jpeg)
WHAT TO KNOW
Ad-Diyar: The biosimilar drugs file in Lebanon is escalating along 3 parallel tracks: judicial, oversight and government, amid accelerated measures to verify the safety of products in circulation, review the mechanisms for registering and importing them, and tighten controls on their access to patients. Judicially, the public prosecutor assigned the deputy prosecutor…
Machine translation of an attributed source excerpt. Consult the original report to verify details. Translated from original reporting in another language.
